HB0192 95TH GENERAL ASSEMBLY

LRB095 03991 DRJ 24024 b

95TH GENERAL ASSEMBLY
State of Illinois
2007 and 2008
HB0192

Introduced 1/19/2007, by Rep. Mary E. Flowers

SYNOPSIS AS INTRODUCED:

20 ILCS 1705/10.5 new
20 ILCS 2310/2310-312 new
110 ILCS 330/7 new
210 ILCS 85/6.23 new

Amends the Mental Health and Developmental Disabilities Administrative Act, the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois, the University of Illinois Hospital Act, and the Hospital Licensing Act. Requires the Department of Public Health to perform certain functions in relation to the prevention and control of Multidrug-Resistant Organisms (MDROs). In particular, requires the Department to: (1) adopt rules for all health care facilities subject to licensure, certification, registration, or other regulation by the Department requiring compliance with the 2006 recommendations of the U.S. Centers for Disease Control and Prevention for the prevention and control of MDROs; (2) conduct a public information campaign for health care providers not subject to regulation by the Department; (3) create and administer a training program for health care providers; and (4) recommend and approve tests or testing procedures used in determining, preventing, and controlling MDRO infection. Requires hospitals (including the University of Illinois Hospital) and Department of Human Services mental health and developmental disability facilities to implement comprehensive interventions and routine testing procedures. Effective immediately.

FISCAL NOTE ACT MAY APPLY

A BILL FOR

AN ACT concerning health.

Be it enacted by the People of the State of Illinois, represented in the General Assembly:

Section 5. The Mental Health and Developmental Disabilities Administrative Act is amended by adding Section 10.5 as follows:

(20 ILCS 1705/10.5 new)

Sec. 10.5. Prevention and control of Multidrug-Resistant Organisms. The Department, in consultation with the Department of Public Health, shall adopt rules requiring facilities described in Section 4 of this Act to implement comprehensive interventions to prevent and control multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococcci (VRE), and certain gram-negative bacilli (GNB), pursuant to prevention and control interventions recommended by the U.S. Centers for Disease Control and Prevention (2006). The Department shall also require facilities to submit reports to the Department that contain substantially the same information contained in the related infection reports required to be submitted by hospitals to the Department of Public Health under Section 25 of the Hospital Report Card Act. The Department shall provide that information to the Department of Public Health upon the Department of Public Health's request.

In addition to requiring implementation of the interventions recommended by the U.S. Centers for Disease Control and Prevention, the Department shall require facilities to establish and implement procedures for routinely testing all patients for methicillin-resistant Staphylococcus aureus (MRSA) (i) upon admission to the facility and (ii) on a repeated basis as necessary to prevent the infection of other facility patients or facility personnel or visitors.

Section 10. The Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois is amended by adding Section 2310-312 as follows:

(20 ILCS 2310/2310-312 new)

Sec. 2310-312. Multidrug-Resistant Organisms. The Department shall perform the following functions in relation to the prevention and control of Multidrug-Resistant Organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant (VRE) and certain gram-negative bacilli (GNB), as these terms are referenced by the United States Centers for Disease Control and Prevention:

(1) The Department shall adopt administrative rules for all health care facilities subject to licensure, certification, registration, or other regulation by the Department requiring compliance with the 2006 recommendations of the U.S. Centers for Disease Control and Prevention for the prevention and control of Multidrug-Resistant Organisms (MDROs).

(2) The Department shall conduct a public information campaign for health care providers not subject to regulation by the Department, including physicians, health facilities, public health departments, other public and private health care providers, laboratories, and the general public, on Multidrug Resistant Organisms (MDROs) to reduce the incidence of infection. This program shall include, but need not be limited to, the establishment of a statewide information clearinghouse that will provide periodic reports and releases to public officials, health professionals, and the general public regarding new developments or procedures concerning prevention and treatment of MDROs.

(3) The Department shall create and administer a training program for health care providers who have a need for understanding matters relating to MDROs. The training shall include information on the cause and effects of MDROs and the means of preventing and controlling transmission. The training may be made available to public employees and the employees of private agencies. The Department may charge fees to cover the costs of the training.

(4) The Department shall recommend and approve tests or testing procedures used in determining, preventing, and controlling MDRO infection.

Section 15. The University of Illinois Hospital Act is amended by adding Section 7 as follows:

(110 ILCS 330/7 new)

Sec. 7. Prevention and control of Multidrug-Resistant Organisms. The University, in consultation with the Department of Public Health, shall adopt rules requiring the University of Illinois hospital to implement comprehensive interventions to prevent and control multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococcci (VRE), and certain gram-negative bacilli (GNB), pursuant to prevention and control interventions recommended by the U.S. Centers for Disease Control and Prevention (2006). The University shall also require the Hospital to submit reports to the University that contain substantially the same information contained in the related infection reports required to be submitted by hospitals to the Department of Public Health under Section 25 of the Hospital Report Card Act. The University shall provide that information to the Department of Public Health upon the Department's request.

In addition to requiring implementation of the interventions recommended by the U.S. Centers for Disease Control and Prevention, the University shall require the University of Illinois Hospital to establish and implement procedures for routinely testing all patients for methicillin-resistant Staphylococcus aureus (MRSA) (i) upon admission to the hospital and (ii) on a repeated basis as necessary to prevent the infection of other hospital patients or hospital personnel or visitors.

Section 20. The Hospital Licensing Act is amended by adding Section 6.23 as follows:

(210 ILCS 85/6.23 new)

Sec. 6.23. Prevention and control of Multidrug-Resistant Organisms. The Department shall adopt rules requiring hospitals licensed under this Act to implement comprehensive interventions to prevent and control multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococcci (VRE), and certain gram-negative bacilli (GNB), pursuant to prevention and control interventions recommended by the U.S. Centers for Disease Control and Prevention (2006). The Department shall also require hospitals to submit related infection reports under Section 25 of the Hospital Report Card Act.

In addition to requiring implementation of the interventions recommended by the U.S. Centers for Disease Control and Prevention, the Department shall require hospitals to establish and implement procedures for routinely testing all patients for methicillin-resistant Staphylococcus aureus (MRSA) (i) upon admission to the hospital and (ii) on a repeated basis as necessary to prevent the infection of other hospital patients or hospital personnel or visitors.

Section 99. Effective date. This Act takes effect upon becoming law.